Form 4: TransDigm Director W. Nicholas Howley Executes Stock Option and Sells Shares

Sentiment:

SEC Form 4 Filing


TransDigm Group director W. Nicholas Howley exercised stock options and sold a portion of his holdings on November 15, 2024.

Summary

  • On November 15, 2024, W. Nicholas Howley, a director at TransDigm Group Inc., exercised stock options to acquire 5,472 shares of common stock at a price of $140.92 per share.
  • Following the exercise of the options, Mr. Howley sold a total of 4,448 shares of common stock through his family trust.
  • The sales were executed at varying prices ranging from $1,258.51 to $1,278.53 per share.
  • The transactions were made under a pre-arranged 10b5-1 trading plan.
  • After these transactions, Mr. Howley's family trust indirectly holds 21,547.513 shares of TransDigm common stock and 94,898 stock options.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing detailing insider transactions, which is neither positive nor negative in itself. The transactions are part of a pre-arranged plan.

Industry Context

This is a routine filing related to insider transactions and is common for publicly traded companies. It provides transparency into the trading activities of company directors.

Comparison to Industry Standards

  • Form 4 filings are standard practice for publicly traded companies in the US, and this filing is consistent with those requirements.
  • The use of a 10b5-1 trading plan is a common method for insiders to manage their stock sales while avoiding accusations of insider trading.
  • The share sales are not unusual in the context of executive compensation and portfolio management.

Stakeholder Impact

  • The transactions may have a minor impact on the stock price due to the volume of shares sold, but this is likely to be minimal given the pre-arranged nature of the sales.

Key Dates

DateDescription
09/30/2017Date the stock options became exercisable.
04/23/1999Date of the W. Nicholas Howley Family Trust agreement.
11/10/2026Expiration date of the stock options.
11/15/2024Date of the stock option exercise and share sales.
11/19/2024Date the Form 4 was signed.

Keywords

TransDigm, stock options, insider trading, share sales, Form 4, W. Nicholas Howley, 10b5-1 plan

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.